Small Business Majority has created a comprehensive state policy agenda to ensure entrepreneurship is at the center of a thriving and inclusive economy in Georgia. The state’s 1 million small businesses comprise 99.6% of all businesses in the state, and they employ 1.6 million residents—nearly half of all Georgia employees.
Today, Government Affairs Director, Awesta Sarkash, submitted a letter to the DC Council's Committee on Health and Business & Economic Development opposing B24-0305, the Professional Employer Oganization Registration Act of 2021. This bill would require professional employer organizations that offer health insurance in the District to register with the Department of Insurance, Securities, and Banking. This bill would have negative impacts on the marketplace—and consequently on small businesses that already struggle with healthcare costs.
On February 16, LaJuanna Russell, founder and president of Business Management Associates, Inc. (BMA) and the Chair of the Board of Directors and a member of the Small Business Council for Small Business Majority, testified before the U.S. House Committee on the Budget on a proposal to eliminate the U.S. debt limit, which would help mitigate financial risks and uncertainty for businesses of all sizes.
On February 16, Small Business Majority's Colorado Director Lindsey Vigoda testified before the House Business Affairs and Labor Committee on reducing costly fees associated with business registrations for aspiring and current Colorado entrepreneurs. Reducing or waiving business-related fees will remove just one of the many financial barriers on entrepreneurs who are scrambling to keep their businesses afloat.
Today, John Arensmeyer submitted comments on the notice of proposed rulemaking (NPRM) issued by the Treasury Department’s Financial Crimes Enforcement Network (FinCEN), titled “Beneficial Ownership Information Reporting Requirements” (RIN 1506-AB49), regarding the implementation of the recently enacted Corporate Transparency Act of 2020 (CTA). An anti-money laundering measure, the CTA requires FinCEN to establish a secure database to which U.S. companies submit basic identifying information of their true, “beneficial” owners.
Today, Government Affairs Director Awesta Sarkash, submitted a letter of support to the Senate Commerce and Labor Committee during the 2022 Virginia General Assembly in support of SB 1, which would create a paid family and medical program in the Commonwealth of Virginia. The COVID-19 pandemic has underscored the importance of accessing paid family and medical leave. Now more than ever, there is a need for a modernized and robust benefits infrastructure, which would greatly benefit small business owners and their employees.
Small Business Majority has created a comprehensive state policy agenda to ensure entrepreneurship is at the center of a thriving and inclusive economy in Colorado.
Today, Small Business Majority along with 13 local, state, and national organizations, sent a letter to President Joe Biden, Senate Majority Leader Charles Schumer, and West Virginia Senator Joe Manchin urging the leaders to reignite negotiations surrounding the Build Back Better package. The Build Back Better package provisions include access to affordable healthcare, childcare, paid family and medical leave, and leveling the playing field on taxes, which would benefit the small business ecosystem.
Small Business Majority’s policy agenda ensures that small business is at the center of a thriving and inclusive economy in Wisconsin and advances policies that promote equitable pathways for entrepreneurship. The state’s 461,000 small businesses employed 1.3 million people in 2021, and small businesses have historically driven job growth . Yet, small businesses in Wisconsin continue to face setbacks from the COVID-19 crisis and struggle to access critical financing and resources.
Today, Awesta Sarkash, Government Affairs Director, submitted a letter in support of SB 376 which would create a prescription drug affordability review board in Virginia. The review board would protect state residents, state and local governments, commercial health plans, health care providers, pharmacies licensed in the Commonwealth, and other stakeholders within the health care system from the high costs of prescription drug products.